These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16200542

  • 1. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK, Hong SS, Choi YJ, Park SH, Ahn H, Kim CS, Cho KS.
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, Kitagaki H, Igawa M.
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [Abstract] [Full Text] [Related]

  • 3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW.
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [Abstract] [Full Text] [Related]

  • 4. Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging.
    Kitajima K, Kaji Y, Fukabori Y, Yoshida K, Suganuma N, Sugimura K.
    J Magn Reson Imaging; 2010 Mar; 31(3):625-31. PubMed ID: 20187206
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
    Sung YS, Kwon HJ, Park BW, Cho G, Lee CK, Cho KS, Kim JK.
    AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
    [Abstract] [Full Text] [Related]

  • 6. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
    Franiel T, Lüdemann L, Rudolph B, Rehbein H, Staack A, Taupitz M, Prochnow D, Beyersdorff D.
    Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
    [Abstract] [Full Text] [Related]

  • 8. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
    Gemeinhardt O, Lüdemann L, Prochnow D, Abramjuk C, Taupitz M, Hamm B, Beyersdorff D.
    Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
    [Abstract] [Full Text] [Related]

  • 9. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA, Cutajar M, Gordon I.
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [Abstract] [Full Text] [Related]

  • 10. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
    Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):425-30. PubMed ID: 17881141
    [Abstract] [Full Text] [Related]

  • 11. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S, Baghi M, Wagenblast J, Bisdas T, Thng CH, Mack MG, Koh TS, Ernemann U.
    Clin Physiol Funct Imaging; 2009 Sep 01; 29(5):339-46. PubMed ID: 19473200
    [Abstract] [Full Text] [Related]

  • 12. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
    Oto A, Fan X, Mustafi D, Jansen SA, Karczmar GS, Rubin DT, Kayhan A.
    Acad Radiol; 2009 Oct 01; 16(10):1223-30. PubMed ID: 19524458
    [Abstract] [Full Text] [Related]

  • 13. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
    Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S.
    J Magn Reson Imaging; 2007 Jan 01; 25(1):146-52. PubMed ID: 17139633
    [Abstract] [Full Text] [Related]

  • 14. A general dual-bolus approach for quantitative DCE-MRI.
    Kershaw LE, Cheng HL.
    Magn Reson Imaging; 2011 Feb 01; 29(2):160-6. PubMed ID: 21129878
    [Abstract] [Full Text] [Related]

  • 15. [Pharmacokinetic MRI of the prostate: parameters for differentiating low-grade and high-grade prostate cancer].
    Franiel T, Lüdemann L, Taupitz M, Rost J, Asbach P, Beyersdorff D.
    Rofo; 2009 Jun 01; 181(6):536-42. PubMed ID: 19353483
    [Abstract] [Full Text] [Related]

  • 16. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
    Cornud F, Beuvon F, Thévenin F, Chauveinc L, Vieillefond A, Descazeaux A, Flam T.
    Prog Urol; 2009 Jun 01; 19(6):401-13. PubMed ID: 19467459
    [Abstract] [Full Text] [Related]

  • 17. T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlations.
    Valentini AL, Gui B, Cina A, Pinto F, Totaro A, Pierconti F, Bassi PF, Bonomo L.
    Eur J Radiol; 2012 Nov 01; 81(11):3090-5. PubMed ID: 22727777
    [Abstract] [Full Text] [Related]

  • 18. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region.
    Kim JH, Kim JK, Park BW, Kim N, Cho KS.
    J Magn Reson Imaging; 2008 Nov 01; 28(5):1173-9. PubMed ID: 18837000
    [Abstract] [Full Text] [Related]

  • 19. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
    Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA.
    J Magn Reson Imaging; 2009 Aug 01; 30(2):327-34. PubMed ID: 19629981
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of semi-quantitative dynamic contrast-enhanced MRI parameters for prostate cancer in correlation to whole-mount histopathology.
    Isebaert S, De Keyzer F, Haustermans K, Lerut E, Roskams T, Roebben I, Van Poppel H, Joniau S, Oyen R.
    Eur J Radiol; 2012 Mar 01; 81(3):e217-22. PubMed ID: 21349667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.